Vijaya leaf, Ayurvedic lineage, modern clinical rigour.
Cannadoc is the first apothecary in India dispensing Vijaya formulations under AYUSH licence — every batch lab-verified, every formulation prescribed by a registered physician.
Licensed under the Department of AYUSH, Madhya Pradesh · Manufactured in GMP-certified facilities · Vijaya formulations dispensed against prescription · Moksa functional mushrooms ship as dietary supplements.
A small range, deeply considered.
Three formulations today — Vijaya nervines for stress and sleep, and a Moksa functional-mushroom trio for daily resilience. Every product is licensed, lab-verified, and dispensed only against a valid prescription.
Calm Down · 1 box
Vijaya nervines + Brahmi, Ashwagandha and Jatamansi. One gummy a day for 30 days. AYUSH prescription required — included free with our 15-min physician consultation.
Deep Sleep · 1 box
Tagar, Vijaya, Jatamansi and Ashwagandha — for sleep onset without the residual heaviness of conventional sedatives. AYUSH prescription required, included with our free consultation.
Moksa Mushroom Trio
Cordyceps for morning energy, Lion's Mane for midday focus, Reishi for evening calm. One month of the daily trio — a dietary supplement, no prescription needed.
Free physician consultation.
Vijaya is AYUSH-scheduled, so a valid prescription is required for any Calm Down or Deep Sleep order. Our physicians issue this in a 15-minute consultation — free, no obligation to buy.
Tell us a little about your health and what you're hoping to address. A physician will review your form and reach out within one working day to schedule the consultation.
Your details are sent only to the consulting physician. We do not share, sell or use them for marketing.
Conditions our physicians address.
-
Anxiety. Vijaya nervines with Brahmi, Ashwagandha and Jatamansi — stress modulation without the morning fog of conventional anxiolytics.
-
Insomnia. Tagar, Vijaya, Jatamansi and Ashwagandha — sleep onset and architecture without the residual heaviness of conventional sedatives.
-
Chronic pain. Ayurvedic internal formulations prescribed adjunctively to your existing regimen.
-
Inflammation. Vijaya alongside classical Ayurvedic anti-inflammatories — backed by clinical literature (Whiting et al., JAMA 2015).
-
Digestive support. Functional mushrooms (Reishi, Lion's Mane) and herbal protocols — a 4–8 week daily ritual.
-
Daily resilience. The Moksa Trio — Cordyceps morning, Lion's Mane mid-day, Reishi evening — for cognition, energy and recovery.
AYUSH MP LICENSED
GMP CERTIFIED
LAB VERIFIED
AYURVEDIC LINEAGE
A leaf, three thousand years in continuous practice.
The story of Vijaya — cannabis sativa — is not new. It is among the oldest documented therapeutic plants in the Indian subcontinent. What follows is its abridged biography.
Atharva Veda
Vijaya is named among the five sacred plants of India, said to release anxiety and sustain joy.
Sushruta Samhita
Documented as a treatment for catarrh, diarrhoea, and as an analgesic during surgical procedures.
Charaka Samhita
Vijaya is listed among the herbs that pacify Vata dosha and restore mental equilibrium.
Bhavaprakasha Nighantu
An exhaustive Ayurvedic pharmacopoeia describing Vijaya as nidrajanaka (sleep-inducing) and pittala (mood-modulating).
Govt. of Madhya Pradesh
Issues licenses under the AYUSH Department for cultivation and processing of Vijaya for therapeutic use.
CannaDoc
Bridges Ayurvedic lineage with contemporary clinical evidence — every formulation prescription-only.
Cannabis use in India and Tibet for medicinal and religious purposes is documented across more than three millennia of continuous textual record.
TOUW, M. — J. PSYCHOACTIVE DRUGS — 1981What our patients tell us.
"Three weeks on Calm Down and the morning dread is gone. I sleep through the night. My therapist noticed before I did."
"Deep Sleep doesn't knock me out — I wake up rested, not foggy. First time in fifteen years I'm not reaching for the alarm with dread."
"The Moksa trio gave me steady energy without coffee jitters. Cordyceps in the morning has changed how I train. Lion's Mane at lunch keeps me focused through deep work."
"The free physician consultation alone was worth the visit. They asked about my full medication list before prescribing, which my GP never did."
"I was sceptical of an Ayurvedic gummy. The lab certificates and the physician consultation changed my mind. Calm Down has replaced my benzodiazepine prescription, with my psychiatrist's blessing."
"After eight weeks on the Moksa Reishi (evening) my immune flare-ups have settled. The packaging and the patient leaflet feel pharmaceutical, not herbal-supplement."
The research behind the formulations.
We don't claim what isn't supported. Below are the peer-reviewed studies that inform our prescribing protocols. Every formulation page links to the studies relevant to its indication.
Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12(4):825–836.
Read →Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente Journal. 2019;23:18-041.
Read →Babson KA, Sottile J, Morabito D. Cannabis, Cannabinoids, and Sleep: A Review of the Literature. Current Psychiatry Reports. 2017;19(4):23.
Read →Kuhathasan N, Dufort A, MacKillop J, et al. The use of cannabinoids for sleep: A critical review on clinical trials. Experimental and Clinical Psychopharmacology. 2019;27(4):383–401.
Read →Bergamaschi MM, Queiroz RH, Chagas MH, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011;36(6):1219–1226.
Read →Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–2473.
Read →Russo EB. Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management. 2008;4(1):245–259.
Read →Touw M. The religious and medicinal uses of Cannabis in China, India and Tibet. Journal of Psychoactive Drugs. 1981;13(1):23–34.
Read →Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research. 2009;23(3):367–372.
Read →Nagano M, Shimizu K, Kondo R, et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research. 2010;31(4):231–237.
Read →Saitsu Y, Nishide A, Kikushima K, Shimizu K, Ohnuki K. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomedical Research. 2019;40(4):125–131.
Read →Tang W, Gao Y, Chen G, et al. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. Journal of Medicinal Food. 2005;8(1):53–58.
Read →Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. J Altern Complement Med. 2010;16(5):585–590.
Read →Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG. Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. J Dietary Suppl. 2017;14(1):42–53.
Read →Torkelson CJ, Sweet E, Martzen MR, et al. Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer. ISRN Oncology. 2012;2012:251632.
Read →Glamočlija J, Ćirić A, Nikolić M, et al. Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal 'mushroom'. Journal of Ethnopharmacology. 2015;162:323–332.
Read →Konno S, Tortorelis DG, Fullerton SA, Samadi AA, Hettiarachchi J, Tazaki H. A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients. Diabetic Medicine. 2001;18(12):1010.
Read →